Home Press Releases Old school blood pressure medication prevent COPD exacerbations

Old school blood pressure medication prevent COPD exacerbations

Acute chronic obstructive pulmonary disease (COPD) exacerbations may be reduced by beta-blockers, a medication widely used to treat heart failure and high blood pressure, according to a featured trial released in the New England Journal of Medicine.

Background: A substantial majority of COPD-related morbidity, mortality and health care costs are due to acute exacerbations, but existing medications have only a modest effect on reducing their frequency, even when used in combination.

Session Name: New England Journal of Medicine Featured Trial: Beta-Blockers for the Prevention of Acute Exacerbations of COPD
Date/Time: Sunday, October 20 at 1:00 p.m. - 2:00 p.m. CT
Location: CHEST Annual Meeting 2019
Room 393


  • Mark Dransfield, M.D., from the University of Alabama at Birmingham, will address the effects of beta-blockers for the prevention of acute COPD exacerbations.
  • Gerard Criner, M.D., from Temple University Hospital, will discuss treatment plan changes for acute COPD exacerbations.

Contact: Amy Jenkins
CHEST Press Room
Mobile + 1 (312) 371-8365

CHEST 2019 is the 85th annual meeting for the American College of Chest Physicians held Oct. 19 to Oct. 23, 2019, in New Orleans. The American College of Chest Physicians, publisher of the journal CHEST®, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research and team-based care. Its mission is to champion the prevention, diagnosis and treatment of chest diseases through education, communication and research. It serves as an essential connection to clinical knowledge and resources for its 19,000 members from around the world who provide patient care in pulmonary, critical care and sleep medicine. For more information about CHEST 2019, visit chestmeeting.chestnet.org, or follow CHEST meeting hashtag, #CHEST2019, on social media.